Literature DB >> 7124864

Effects of nifedipine on spontaneous and methylergometrine-induced activity post partum.

A Forman, P Gandrup, K E Andersson, U Ulmsten.   

Abstract

Intrauterine pressure changes were recorded by microtransducer catheter in 17 women immediately post partum. In all patients, spontaneous contractile activity was recorded, characterized by high contraction amplitudes (110 to 350 mm Hg). The calcium entry blocker nifedipine effectively inhibited these contractions. Both in vitro, in strips of pregnant myometrium, and in vivo, methylergometrine induced a contractile activity that could be blocked by nifedipine. The conclusion is that, for the testing of drugs that affect the contractile activity of pregnant myometrium, the use of intrauterine pressure recording by microtransducer catheters in the early postpartum period provides a suitable model.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7124864     DOI: 10.1016/0002-9378(82)90251-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Some observations on the effects of a calcium channel blocker, nitrendipine, in early human pregnancy.

Authors:  M R Lawrence; F Broughton Pipkin
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

Review 3.  Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology.

Authors:  A N de Groot; P W van Dongen; T B Vree; Y A Hekster; J van Roosmalen
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

4.  Nifedipine kinetics in the rat and relationship between its serum concentrations and uterine and cardiovascular effects.

Authors:  S J Downing; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.